PONTREMOLI, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 23.581
AS - Asia 1.924
NA - Nord America 1.555
SA - Sud America 153
AF - Africa 30
OC - Oceania 18
Totale 27.261
Nazione #
IT - Italia 23.232
US - Stati Uniti d'America 1.442
SG - Singapore 894
CN - Cina 509
VN - Vietnam 291
FR - Francia 184
BR - Brasile 97
BD - Bangladesh 63
HK - Hong Kong 49
CA - Canada 40
DE - Germania 36
JP - Giappone 28
AR - Argentina 26
FI - Finlandia 25
GB - Regno Unito 21
MX - Messico 19
AU - Australia 18
JM - Giamaica 17
CH - Svizzera 14
IN - India 14
NL - Olanda 13
ID - Indonesia 11
CO - Colombia 10
ES - Italia 9
IQ - Iraq 9
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
HN - Honduras 7
TR - Turchia 7
ZA - Sudafrica 7
EC - Ecuador 6
IE - Irlanda 6
GT - Guatemala 5
JO - Giordania 5
KR - Corea 5
PH - Filippine 5
RO - Romania 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
KE - Kenya 4
KZ - Kazakistan 4
PL - Polonia 4
RU - Federazione Russa 4
UA - Ucraina 4
CL - Cile 3
DZ - Algeria 3
MA - Marocco 3
NI - Nicaragua 3
PE - Perù 3
SE - Svezia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
VE - Venezuela 3
BE - Belgio 2
BO - Bolivia 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
MT - Malta 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
PR - Porto Rico 2
RS - Serbia 2
TG - Togo 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
Totale 27.261
Città #
Genova 15.497
Genoa 4.375
Rapallo 1.858
Vado Ligure 1.383
San Jose 489
Singapore 422
Lauterbourg 172
Ashburn 95
New York 85
Ho Chi Minh City 78
Beijing 61
Hanoi 52
Hong Kong 45
Santa Clara 44
Frankfurt am Main 32
Tokyo 26
Helsinki 25
Los Angeles 18
Council Bluffs 17
Chicago 16
Da Nang 16
Bordighera 15
Tianjin 15
Haiphong 14
Zurich 14
Phoenix 13
Amsterdam 11
Buffalo 11
Kingston 11
Mexico City 11
Montreal 11
Houston 10
Rome 10
Dallas 9
Jacksonville 9
Milan 9
Toronto 9
Washington 9
San Francisco 8
Naples 7
São Paulo 7
Atlanta 6
Brooklyn 6
Dublin 6
Hải Dương 6
Madrid 6
Orem 6
Des Moines 5
Guatemala City 5
Newark 5
Rio de Janeiro 5
San José 5
Sydney 5
Amman 4
Baghdad 4
Cardiff 4
Charlotte 4
City of London 4
Cleveland 4
Detroit 4
Durham 4
Guangzhou 4
Iowa City 4
Istanbul 4
Jeddah 4
Johannesburg 4
London 4
Miami 4
Mumbai 4
Nha Trang 4
Ninh Bình 4
Palermo 4
Paris 4
Queens 4
Quảng Ngãi 4
Sumter 4
The Bronx 4
Wuhan 4
Abu Dhabi 3
Acalanes Ridge 3
Bari 3
Biên Hòa 3
Bogotá 3
Brasília 3
Buenos Aires 3
Cagliari 3
Can Tho 3
Catania 3
Changsha 3
Curtea de Argeş 3
Dhaka 3
Florence 3
Fortaleza 3
Greensboro 3
Huntsville 3
Indpls 3
Marseille 3
Morganville 3
Nairobi 3
New Orleans 3
Totale 25.251
Nome #
"Intracellular calpastatin proteolysis: a salvage mechanism or a prelude to cell damage?" 267
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 249
Calpain digestion and HSP90-based chaperone protection modulate the level of plasma membrane F508del-CFTR. 247
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 231
Role of the calpain-calpastatin system in the density-dependent growth arrest 215
A vincristine-resistant murine erythroleukemia cell line secretes a differentiation enhancing factor. 213
Acyl-CoA-binding protein is a potent m-calpain activator 210
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 201
Autolysis of human erythrocytes calpain produces two active enzyme forms with different cell localization 200
Modulation of the calpain autoproteolysis by calpastatin and phospholipids 198
Characterization of a new p94-like calpain form in human lymphocytes 198
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 195
Effect of extremely low frequency magnetic fields on calpain activation 193
Activation by hemoglobin of the Ca2+-requiring neutral proteinase of human erythrocytes: structural requirements. 192
Activation of neutrophil calpain following its translocation to the plasma membrane induced by phorbol ester or fMet-Leu-Phe.. 191
Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex. 190
Binding to erythrocyte membrane is the physiological mechanism for activation of Ca2+-dependent neutral proteinase. 188
Differential regulation of the calpain-calpastatin complex by the L-domain of calpastatin 188
Involvement of exon 6-mediated calpastatin intracellular movements in the modulation of calpain activation. 187
Pathological role of the calpain/calpastatin system in cystic fibrosis 184
Carbon tetrachloride-induced inhibition of protein kinase C in isolated rat hepatocytes. 183
Degradation of CFTR-generated protein clusters by calpain: A physiological or a pathological role? 179
Activation of A431 human carcinoma cell motility by extracellular high-mobility group box 1 protein and epidermal growth factor stimuli 179
Activation of NADPH oxidase and phosphorylation of membrane proteins in human neutrophils: coordinate inhibition by a surface antigen-directed monoclonal antibody. 176
Changes during fasting in the activity of a specific lysosomal proteinase, fructose-1,6-bisphosphatase converting enzyme. 174
Characterization of the defective calpain-endogenous calpain inhibitor system in erythrocytes from Milan hypertensive rats. 173
A dual role for the Ca2+-requiring proteinase in the degradation of hemoglobin by erythrocyte membrane proteinases. 172
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 171
Changes in calpastatin localization and expression during calpain activation: a new mechanism for the regulation of intracellular Ca(2+)-dependent proteolysis. 171
Regulation of calpain activity in rat brain with altered Ca2+ homeostasis 171
Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase. 171
Glucose 6-phosphate dehydrogenase activity in membranes of erythrocytes from normal individuals and subjects with Mediterranean G6PD deficiency. 171
Characterization of the inactive form of fructose-1,6-bisphosphate aldolase isolated from livers of fasted rabbits. 171
Properties and intracellular localization of calpain activator protein 171
Cathepsin M: a lysosomal proteinase with aldolase-inactivating activity 170
Changes in rabbit-liver lysosomes and fructose 1,6-bisphosphatase induced by cold and fasting. 170
Multiple rat brain calpastatin forms are produced by distinct starting points and alternative splicing of the N-terminal exons. 168
Changes in intracellular localization of calpastatin during calpain activation 167
Binding of Zn2+ to rabbit muscle fructose 1,6-bisphosphatase and its effect on the catalytic properties. 167
Interactions of Zn2+ and Mg2+ with rabbit liver fructose 1,6 bisphosphatase. 167
On the mechanism of inhibition of fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. 166
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein. 165
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 164
"Association of calpastatin with inactive calpain: a novel mechanism to control the activation of the protease?" 164
Protein kinase C isoforms in murine erythroleukemia cells and their involvement in the differentiation process. 164
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 163
Interaction between Calpain-1 and HSP90: New Insights into the Regulation of Localization and Activity of the Protease. 162
Antisense oligodeoxynucleotide inhibition of delta protein kinase C expression accelerates induced differentiation of murine erythroleukaemia cells 161
Cytosolic calcium dependent proteinase of human erythrocytes: formation of an enzyme-natural inhibitor complex induced by Ca2+ ions. 161
Changes in intracellular calpastatin localization are mediated by reversible phosphorylation 161
Extralysosomal protein degradation. 159
Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90. 159
Binding of monoclonal antibody to cathepsin M located on the external surface of rabbit lysosomes. 159
Comparative patterns of 'in vitro' oxidative hemolysis of normal and glucose 6-phosphate dehydrogenase (G6PD)-deficient erythrocytes. 159
Age-dependent degradation of calpastatin in kidney of hypertensive rats 159
“In vivo degradation of Nitric-Oxide Synthase isozymes by Calpain is regulated by HSP90” 159
Identification of a novel neutrophil membrane protein involved in modulation of oxidative burst. 157
Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase. 157
Inactivation of fructose 1,6-bisphosphatase by a lysosomal proteinase is reversed by cystamine. 156
Inactivation of liver aldolase in fasting rabbits: evidence for the accumulation of two different immunoreactive forms. 156
Changes in activity of fructose-1,6-bisphosphate aldolase in livers of fasted rabbits and accumulation of crossreacting immune material. 156
Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation 154
Decreased level of calpain inhibitor activity in kidney from Milan hypertensive rats. 154
Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation. 154
Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein 154
Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis 154
Role of calpain in the regulation of CFTR (cystic fibrosis transmembrane conductance regulator) turnover 153
The plasma membrane calcium pump is the preferred calpain substrate within the erythrocyte 152
Phosphorylation and proteolytic modification of specific cytoskeletal proteins in human neutrophils stimulated by phorbol 12-myristate 13-acetate. 152
Fructose 1,6-bisphosphatase: the role of lysosomal enzymes in the modification of catalytic and structural properties. 151
Cytosolic levels of calpastatin are regulated by limited proteolysis 151
Isolation and characterization of calpain activator protein from bovine brain. 150
Fructose 1,6-bisphosphatase: properties of the neutral enzyme and its modification by proteolytic enzymes. 150
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 150
ATP induces the release of a neutral serine proteinase and enhances the production of superoxide anion in membranes from phorbol ester-activated neutrophils. 150
Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms. 149
Two cytosolic, Ca2+-dependent, neutral proteinases from rabbit liver: purification and properties of the proenzymes. 149
Role of calpain-1 in the early phase of experimental ALS 149
Fructose-1, 6-diphosphatase from rabbit liver. 148
A Novel signalling mechanism promoting Ca(2+) driven cell responses through high-mobility group box-1/NMDA receptor interaction. 148
Endogenous inhibitors of lysosomal proteinases 148
Differentiation of murine erythroleukemia cells by hexamethylenebisacetamide involves secretion and binding to membranes of a differentiation enhancing factor. 147
Functional role of the charge at the T538 residue in the control of protein kinase Ctheta 145
“Susceptibility of NOS isoforms to calpain digestion is modulated by the expression levels of HSP90” 145
Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation 145
Stimulation of erythroleukaemia cell differentiation by extracellular high mobility group-box protein 1 is independent of receptor for advanced glycation end products. 144
Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells 144
Modulation of the intracellular Ca2+-dependent proteolytic system is critically correlated with the kinetics of differentiation of murine erythroleukemia cells 144
In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency. 144
Different susceptibility of red cell membrane proteins to calpain degradation. 143
The carboxy-terminal amino acid sequence of rabbit liver fructose 1,6-bisphosphatase. 143
Vincristine-resistant erythrolekaemia cell line has marked increase sensitivity to examethylenebisacetamide-induced differentiation 143
An endogenous activator of the Ca2+-dependent proteinase of human neutrophils that increases its affinity for Ca2+. 142
Characterization of the biological role of murine erythroleukemia cells "differentiation enhancing factor" using antisense oligodeoxynucleotides. Biochem. Biophys. Res. Commun. 193, 941-947 141
A 6 kda protein homologous to the N-terminus of the HMG1 protein promoting stimulation of murine erytrolekemia cell differentiation. 141
Introduction of beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells 140
Rabbit liver fructose 1,6-diphosphatase. Properties of the native enzyme and their modification by subtilisin. 140
Origin of tryptophan in fructose 1,6-bisphosphatase purified from livers of fed rabbits. 140
The liver aldolase-fructose bisphosphatase complex. 140
Selective proinflammatory activation of astrocytes by high mobility group box 1 protein signaling 140
Totale 16.677
Categoria #
all - tutte 78.547
article - articoli 72.200
book - libri 0
conference - conferenze 5.653
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 694
Totale 157.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.208 48 144 144 247 99 156 173 453 101 232 94 317
2022/20232.216 203 111 17 288 349 449 1 150 416 10 191 31
2023/2024986 54 131 9 102 139 237 33 34 58 18 50 121
2024/20253.284 176 246 90 204 501 362 246 448 134 124 313 440
2025/20264.749 610 98 216 316 599 543 883 199 435 442 146 262
2026/2027530 530 0 0 0 0 0 0 0 0 0 0 0
Totale 27.372